Skip to content

Investigating the limits of reversibility of type 2 diabetes

Characterisation of the principle determinants of long term reversal of type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN88634530
Enrollment
34
Registered
2012-08-09
Start date
2012-08-31
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Control, Nutrition, Obesity Nutritional, Metabolic, Endocrine Non-insulin-dependent diabetes mellitus

Interventions

Restated interventions as of 31/07/2015: Dietary modification, Very low calorie diet
Physical activity, Increased physical activity levels. The weight maintenance interventions are of 6 months duration and primarily involve a level of calorie intake to maintain weight steady. The rand
Physical activity, Increased physical activity levels. The weight maintenance interventions are of 6 months duration and involve either a high monounsaturated fat diet or usual diet, and increased phy

Sponsors

Newcastle upon Tyne Hospitals NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Type 2 diabetes of 8 years duration 2. HbA1c < 80 mmol/l / 9.5% 3. BMI 28-40kg/m2 4. Age 25-80 years 5. Stable weight for previous 6 months (within 5kg) 6. Male and female participants

Exclusion criteria

Exclusion criteria: 1. Current treatment with thiazolidinediones, GLP-1 agonists or steroids 2. Renal or hepatic dysfunction 3. Contraindications to MRI 4. Alcohol consumption > 3 units per day for women and > 4 units per day for men 5. Allergy to soybean or eggs 6. Highly restrictive diet

Design outcomes

Primary

MeasureTime frame
Restated primary outcome measures as of 31/07/2015: Fasting plasma glucose at 6 months in the group achieving non-diabetic levels at 10 weeks (following VLCD and return to normal eating) Previous primary outcome measures: Beta cell function measured at baseline, 8 weeks and 8 months

Secondary

MeasureTime frame
Added 31/07/2015: Change in beta cell function from 10 weeks to 6 months

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 9, 2026